On 12 Nov 2026 NVR, Inc. closed at $5,814.34, -20.3% this year; market cap $16.16bn, P/E 15.4.
Consumer Discretionary · Homebuilding · NYSE · United States
NVR, Inc. operates as a homebuilder in the United States. The company operates through Homebuilding and Mortgage Banking segments. It engages in the construction and sale of single-family detached homes, townhomes, and condominium buildings under the Ryan Homes, NVHomes, and Heartland Homes names. The company markets its Ryan Homes products to first-time and first-time move-up buyers; and NVHomes and Heartland Homes products to move-up and luxury buyers. It also provides various mortgage related services to its homebuilding customers, as well as brokers title insurance; performs title searches; and sells mortgage loans to investors in the secondary markets on a servicing released basis. The company primarily serves Maryland, Virginia, West Virginia, Delaware, Washington, D.C., New Jersey, Eastern Pennsylvania, New York, Ohio, Western Pennsylvania, Indiana, Illinois, North Carolina, South Carolina, Tennessee, Florida, Georgia, and Kentucky. NVR, Inc. was founded in 1948 and is headquartered in Reston, Virginia.
| Market cap | $16.16bn |
| P/E (trailing) | 15.4 |
| EPS (TTM) | $376.70 |
| Beta | 0.94 |
| Dividend | $0.00 |
| Dividend yield | 0.00% |
| Ex-dividend date | — |
| Latest report | 22 Oct 2026 |
| Next earnings | 21 Jan 2027 |
| YTD | -20.3% |
| 1Y | -20.2% |
| 3Y | -1.2% |
| 5Y | +2.0% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $10.32bn | $1.34bn | $1.10bn |
| 2024 | $10.54bn | $1.68bn | $1.35bn |
| 2023 | $9.53bn | $1.59bn | $1.47bn |
| 2022 | $10.54bn | $1.73bn | $1.85bn |
| 2021 | $8.96bn | $1.24bn | $1.22bn |
We publish no single base value for NVR, Inc. Our valuation methods put it between $2,219.47 and $2,764.61 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.